APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liganlong Granules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liganlong Granules Market Analysis and Forecast 2026-2032

29 December 2025210 pages

Choose your research edition.

Industry ResearchLiganlong Granules Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Liganlong Granules Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Liganlong Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liganlong Granules Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Liganlong Granules Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Liganlong Granules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Liganlong Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liganlong Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liganlong Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liganlong Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Liganlong Granules include Zhongjing Wanxi Pharmaceutical Co., Ltd., Tibet Tibetan Medicine Group Co., Ltd., Sichuan Luye Pharmaceutical Co., Ltd., Liaoning Wohua Kangchen Pharmaceutical Co., Ltd., Liaoning Keji Pharmaceutical Co., Ltd., Liaoning Dongyi Pharmaceutical Co., Ltd., Jiangxi Chuanqi Pharmaceutical Co., Ltd., Jilin Yatai Pharmaceutical Co., Ltd. and Jilin Yinoke Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Liganlong Granules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liganlong Granules, also provides the sales of main regions and countries. Of the upcoming market potential for Liganlong Granules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liganlong Granules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liganlong Granules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Liganlong Granules sales, projected growth trends, production technology, application and end-user industry.

Liganlong Granules Segment by Company

Zhongjing Wanxi Pharmaceutical Co., Ltd.

Tibet Tibetan Medicine Group Co., Ltd.

Sichuan Luye Pharmaceutical Co., Ltd.

Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.

Liaoning Keji Pharmaceutical Co., Ltd.

Liaoning Dongyi Pharmaceutical Co., Ltd.

Jiangxi Chuanqi Pharmaceutical Co., Ltd.

Jilin Yatai Pharmaceutical Co., Ltd.

Jilin Yinoke Pharmaceutical Co., Ltd.

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Heilongjiang Tianhong Pharmaceutical Co., Ltd.

Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.

Hainan Zhongbao Pharmaceutical Co., Ltd.

Sinopharm Group Yibin Pharmaceutical Co., Ltd.

Guizhou Dalong Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.

Guangxi Xiuzhen Pharmaceutical Co., Ltd.

Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.

Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.

Dalian Meiluo Chinese Medicine Factory Co., Ltd.

Dalian Hanfang Pharmaceutical Co., Ltd.

Liganlong Granules Segment by Type

5g

10g

Liganlong Granules Segment by Application

Hospital

Clinic

Other

Liganlong Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liganlong Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liganlong Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liganlong Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Liganlong Granules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Liganlong Granules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liganlong Granules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liganlong Granules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5g Major Manufacturers Table 3. 10g Major Manufacturers Table 4. Global Liganlong Granules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Liganlong Granules Industry Trends Table 9. Liganlong Granules Industry Drivers Table 10. Liganlong Granules Industry Opportunities and Challenges Table 11. Liganlong Granules Industry Restraints Table 12. Global Liganlong Granules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Liganlong Granules Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Liganlong Granules Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Liganlong Granules Revenue Market Share by Region (2021-2026) Table 16. Global Liganlong Granules Revenue Market Share by Region (2027-2032) Table 17. Global Liganlong Granules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Liganlong Granules Sales by Region (2021-2026) & (K Units) Table 19. Global Liganlong Granules Sales by Region (2027-2032) & (K Units) Table 20. Global Liganlong Granules Sales Market Share by Region (2021-2026) Table 21. Global Liganlong Granules Sales Market Share by Region (2027-2032) Table 22. Global Liganlong Granules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Liganlong Granules Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Liganlong Granules Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Liganlong Granules Sales Market Share by Manufacturers (2021-2026) Table 26. Global Liganlong Granules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Liganlong Granules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Liganlong Granules Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Liganlong Granules Manufacturers, Product Type & Application Table 30. Global Liganlong Granules Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Liganlong Granules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Liganlong Granules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Liganlong Granules Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Liganlong Granules Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Liganlong Granules Revenue Market Share by Type (2021-2026) Table 37. Global Liganlong Granules Revenue Market Share by Type (2027-2032) Table 38. Global Liganlong Granules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 40. Global Liganlong Granules Sales by Type (2027-2032) & (K Units) Table 41. Global Liganlong Granules Sales Market Share by Type (2021-2026) Table 42. Global Liganlong Granules Sales Market Share by Type (2027-2032) Table 43. Global Liganlong Granules Price by Type (2021-2026) & (US$/Unit) Table 44. Global Liganlong Granules Price by Type (2027-2032) & (US$/Unit) Table 45. Global Liganlong Granules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Liganlong Granules Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Liganlong Granules Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Liganlong Granules Revenue Market Share by Application (2021-2026) Table 49. Global Liganlong Granules Revenue Market Share by Application (2027-2032) Table 50. Global Liganlong Granules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 52. Global Liganlong Granules Sales by Application (2027-2032) & (K Units) Table 53. Global Liganlong Granules Sales Market Share by Application (2021-2026) Table 54. Global Liganlong Granules Sales Market Share by Application (2027-2032) Table 55. Global Liganlong Granules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Liganlong Granules Price by Application (2027-2032) & (US$/Unit) Table 57. Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information Table 58. Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview Table 59. Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 61. Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Development Table 62. Tibet Tibetan Medicine Group Co., Ltd. Company Information Table 63. Tibet Tibetan Medicine Group Co., Ltd. Business Overview Table 64. Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Product Portfolio Table 66. Tibet Tibetan Medicine Group Co., Ltd. Recent Development Table 67. Sichuan Luye Pharmaceutical Co., Ltd. Company Information Table 68. Sichuan Luye Pharmaceutical Co., Ltd. Business Overview Table 69. Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 71. Sichuan Luye Pharmaceutical Co., Ltd. Recent Development Table 72. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Company Information Table 73. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Business Overview Table 74. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 76. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Recent Development Table 77. Liaoning Keji Pharmaceutical Co., Ltd. Company Information Table 78. Liaoning Keji Pharmaceutical Co., Ltd. Business Overview Table 79. Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 81. Liaoning Keji Pharmaceutical Co., Ltd. Recent Development Table 82. Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information Table 83. Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview Table 84. Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 86. Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Development Table 87. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Company Information Table 88. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Business Overview Table 89. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 91. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Recent Development Table 92. Jilin Yatai Pharmaceutical Co., Ltd. Company Information Table 93. Jilin Yatai Pharmaceutical Co., Ltd. Business Overview Table 94. Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 96. Jilin Yatai Pharmaceutical Co., Ltd. Recent Development Table 97. Jilin Yinoke Pharmaceutical Co., Ltd. Company Information Table 98. Jilin Yinoke Pharmaceutical Co., Ltd. Business Overview Table 99. Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 101. Jilin Yinoke Pharmaceutical Co., Ltd. Recent Development Table 102. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information Table 103. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview Table 104. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 106. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Development Table 107. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information Table 108. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview Table 109. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 111. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Development Table 112. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Company Information Table 113. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Business Overview Table 114. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 116. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Recent Development Table 117. Hainan Zhongbao Pharmaceutical Co., Ltd. Company Information Table 118. Hainan Zhongbao Pharmaceutical Co., Ltd. Business Overview Table 119. Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 121. Hainan Zhongbao Pharmaceutical Co., Ltd. Recent Development Table 122. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information Table 123. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview Table 124. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 126. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Development Table 127. Guizhou Dalong Pharmaceutical Co., Ltd. Company Information Table 128. Guizhou Dalong Pharmaceutical Co., Ltd. Business Overview Table 129. Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 131. Guizhou Dalong Pharmaceutical Co., Ltd. Recent Development Table 132. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information Table 133. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview Table 134. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 136. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Development Table 137. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Company Information Table 138. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Business Overview Table 139. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 141. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Recent Development Table 142. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Company Information Table 143. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Business Overview Table 144. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 146. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Recent Development Table 147. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Company Information Table 148. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Business Overview Table 149. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Product Portfolio Table 151. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Recent Development Table 152. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Company Information Table 153. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Business Overview Table 154. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Product Portfolio Table 156. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Recent Development Table 157. Dalian Hanfang Pharmaceutical Co., Ltd. Company Information Table 158. Dalian Hanfang Pharmaceutical Co., Ltd. Business Overview Table 159. Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 161. Dalian Hanfang Pharmaceutical Co., Ltd. Recent Development Table 162. North America Liganlong Granules Revenue by Type (2021-2026) & (US$ Million) Table 163. North America Liganlong Granules Revenue by Type (2027-2032) & (US$ Million) Table 164. North America Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 165. North America Liganlong Granules Sales by Type (2027-2032) & (K Units) Table 166. North America Liganlong Granules Sales Price by Type (2021-2026) & (US$/Unit) Table 167. North America Liganlong Granules Sales Price by Type (2027-2032) & (US$/Unit) Table 168. North America Liganlong Granules Revenue by Application (2021-2026) & (US$ Million) Table 169. North America Liganlong Granules Revenue by Application (2027-2032) & (US$ Million) Table 170. North America Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 171. North America Liganlong Granules Sales by Application (2027-2032) & (K Units) Table 172. North America Liganlong Granules Sales Price by Application (2021-2026) & (US$/Unit) Table 173. North America Liganlong Granules Sales Price by Application (2027-2032) & (US$/Unit) Table 174. North America Liganlong Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. North America Liganlong Granules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. North America Liganlong Granules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. North America Liganlong Granules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 178. North America Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 179. North America Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 180. North America Liganlong Granules Sales Price by Country (2021-2026) & (US$/Unit) Table 181. North America Liganlong Granules Sales Price by Country (2027-2032) & (US$/Unit) Table 182. United States Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 183. Canada Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 184. Mexico Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 185. Europe Liganlong Granules Revenue by Type (2021-2026) & (US$ Million) Table 186. Europe Liganlong Granules Revenue by Type (2027-2032) & (US$ Million) Table 187. Europe Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 188. Europe Liganlong Granules Sales by Type (2027-2032) & (K Units) Table 189. Europe Liganlong Granules Sales Price by Type (2021-2026) & (US$/Unit) Table 190. Europe Liganlong Granules Sales Price by Type (2027-2032) & (US$/Unit) Table 191. Europe Liganlong Granules Revenue by Application (2021-2026) & (US$ Million) Table 192. Europe Liganlong Granules Revenue by Application (2027-2032) & (US$ Million) Table 193. Europe Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 194. Europe Liganlong Granules Sales by Application (2027-2032) & (K Units) Table 195. Europe Liganlong Granules Sales Price by Application (2021-2026) & (US$/Unit) Table 196. Europe Liganlong Granules Sales Price by Application (2027-2032) & (US$/Unit) Table 197. Europe Liganlong Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. Europe Liganlong Granules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. Europe Liganlong Granules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. Europe Liganlong Granules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 201. Europe Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 202. Europe Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 203. Europe Liganlong Granules Sales Price by Country (2021-2026) & (US$/Unit) Table 204. Europe Liganlong Granules Sales Price by Country (2027-2032) & (US$/Unit) Table 205. Germany Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 206. France Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 207. U.K. Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 208. Italy Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 209. Russia Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 210. Spain Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 211. Netherlands Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 212. Switzerland Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 213. Sweden Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 214. Poland Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 215. China Liganlong Granules Revenue by Type (2021-2026) & (US$ Million) Table 216. China Liganlong Granules Revenue by Type (2027-2032) & (US$ Million) Table 217. China Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 218. China Liganlong Granules Sales by Type (2027-2032) & (K Units) Table 219. China Liganlong Granules Sales Price by Type (2021-2026) & (US$/Unit) Table 220. China Liganlong Granules Sales Price by Type (2027-2032) & (US$/Unit) Table 221. China Liganlong Granules Revenue by Application (2021-2026) & (US$ Million) Table 222. China Liganlong Granules Revenue by Application (2027-2032) & (US$ Million) Table 223. China Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 224. China Liganlong Granules Sales by Application (2027-2032) & (K Units) Table 225. China Liganlong Granules Sales Price by Application (2021-2026) & (US$/Unit) Table 226. China Liganlong Granules Sales Price by Application (2027-2032) & (US$/Unit) Table 227. Asia Liganlong Granules Revenue by Type (2021-2026) & (US$ Million) Table 228. Asia Liganlong Granules Revenue by Type (2027-2032) & (US$ Million) Table 229. Asia Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 230. Asia Liganlong Granules Sales by Type (2027-2032) & (K Units) Table 231. Asia Liganlong Granules Sales Price by Type (2021-2026) & (US$/Unit) Table 232. Asia Liganlong Granules Sales Price by Type (2027-2032) & (US$/Unit) Table 233. Asia Liganlong Granules Revenue by Application (2021-2026) & (US$ Million) Table 234. Asia Liganlong Granules Revenue by Application (2027-2032) & (US$ Million) Table 235. Asia Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 236. Asia Liganlong Granules Sales by Application (2027-2032) & (K Units) Table 237. Asia Liganlong Granules Sales Price by Application (2021-2026) & (US$/Unit) Table 238. Asia Liganlong Granules Sales Price by Application (2027-2032) & (US$/Unit) Table 239. Asia Liganlong Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 240. Asia Liganlong Granules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 241. Asia Liganlong Granules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 242. Asia Liganlong Granules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 243. Asia Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 244. Asia Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 245. Asia Liganlong Granules Sales Price by Country (2021-2026) & (US$/Unit) Table 246. Asia Liganlong Granules Sales Price by Country (2027-2032) & (US$/Unit) Table 247. Japan Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 248. South Korea Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 249. India Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 250. Australia Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 251. Taiwan Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 252. Southeast Asia Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 253. SAMEA Liganlong Granules Revenue by Type (2021-2026) & (US$ Million) Table 254. SAMEA Liganlong Granules Revenue by Type (2027-2032) & (US$ Million) Table 255. SAMEA Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 256. SAMEA Liganlong Granules Sales by Type (2027-2032) & (K Units) Table 257. SAMEA Liganlong Granules Sales Price by Type (2021-2026) & (US$/Unit) Table 258. SAMEA Liganlong Granules Sales Price by Type (2027-2032) & (US$/Unit) Table 259. SAMEA Liganlong Granules Revenue by Application (2021-2026) & (US$ Million) Table 260. SAMEA Liganlong Granules Revenue by Application (2027-2032) & (US$ Million) Table 261. SAMEA Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 262. SAMEA Liganlong Granules Sales by Application (2027-2032) & (K Units) Table 263. SAMEA Liganlong Granules Sales Price by Application (2021-2026) & (US$/Unit) Table 264. SAMEA Liganlong Granules Sales Price by Application (2027-2032) & (US$/Unit) Table 265. SAMEA Liganlong Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 266. SAMEA Liganlong Granules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 267. SAMEA Liganlong Granules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 268. SAMEA Liganlong Granules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 269. SAMEA Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 270. SAMEA Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 271. SAMEA Liganlong Granules Sales Price by Country (2021-2026) & (US$/Unit) Table 272. SAMEA Liganlong Granules Sales Price by Country (2027-2032) & (US$/Unit) Table 273. Brazil Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 274. Argentina Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 275. Chile Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 276. Colombia Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 277. Peru Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 278. Saudi Arabia Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 279. Israel Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 280. UAE Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 281. Turkey Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 282. Iran Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 283. Egypt Liganlong Granules Revenue (2021-2032) & (US$ Million) Table 284. Key Raw Materials Table 285. Raw Materials Key Suppliers Table 286. Liganlong Granules Distributors List Table 287. Liganlong Granules Customers List Table 288. Research Programs/Design for This Report Table 289. Authors List of This Report Table 290. Secondary Sources Table 291. Primary Sources List of Figures Figure 1. Liganlong Granules Image Figure 2. Global Liganlong Granules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liganlong Granules Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5g Image Figure 5. 10g Image Figure 6. Global Liganlong Granules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Liganlong Granules Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Liganlong Granules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Liganlong Granules Revenue (2021-2032) & (US$ Million) Figure 13. Global Liganlong Granules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Liganlong Granules Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Liganlong Granules Revenue Market Share by Region (2021-2032) Figure 16. Global Liganlong Granules Sales (2021-2032) & (K Units) Figure 17. Global Liganlong Granules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Liganlong Granules Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Liganlong Granules Sales YoY (2021-2032) & (K Units) Figure 20. Europe Liganlong Granules Sales YoY (2021-2032) & (K Units) Figure 21. China Liganlong Granules Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Liganlong Granules Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Liganlong Granules Sales YoY (2021-2032) & (K Units) Figure 24. Global Liganlong Granules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Liganlong Granules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Liganlong Granules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Liganlong Granules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Liganlong Granules Revenue Market Share by Type (2021-2032) Figure 30. Global Liganlong Granules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Liganlong Granules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Liganlong Granules Sales Market Share by Type (2021-2032) Figure 33. Global Liganlong Granules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Liganlong Granules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Liganlong Granules Revenue Market Share by Application (2021-2032) Figure 36. Global Liganlong Granules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Liganlong Granules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Liganlong Granules Sales Market Share by Application (2021-2032) Figure 39. North America Liganlong Granules Revenue Share by Type (2021-2032) Figure 40. North America Liganlong Granules Sales Share by Type (2021-2032) Figure 41. North America Liganlong Granules Revenue Share by Application (2021-2032) Figure 42. North America Liganlong Granules Sales Share by Application (2021-2032) Figure 43. North America Liganlong Granules Revenue Share by Country (2021-2032) Figure 44. North America Liganlong Granules Sales Share by Country (2021-2032) Figure 45. Europe Liganlong Granules Revenue Share by Type (2021-2032) Figure 46. Europe Liganlong Granules Sales Share by Type (2021-2032) Figure 47. Europe Liganlong Granules Revenue Share by Application (2021-2032) Figure 48. Europe Liganlong Granules Sales Share by Application (2021-2032) Figure 49. Europe Liganlong Granules Revenue Share by Country (2021-2032) Figure 50. Europe Liganlong Granules Sales Share by Country (2021-2032) Figure 51. China Liganlong Granules Revenue Share by Type (2021-2032) Figure 52. China Liganlong Granules Sales Share by Type (2021-2032) Figure 53. China Liganlong Granules Revenue Share by Application (2021-2032) Figure 54. China Liganlong Granules Sales Share by Application (2021-2032) Figure 55. Asia Liganlong Granules Revenue Share by Type (2021-2032) Figure 56. Asia Liganlong Granules Sales Share by Type (2021-2032) Figure 57. Asia Liganlong Granules Revenue Share by Application (2021-2032) Figure 58. Asia Liganlong Granules Sales Share by Application (2021-2032) Figure 59. Asia Liganlong Granules Revenue Share by Country (2021-2032) Figure 60. Asia Liganlong Granules Sales Share by Country (2021-2032) Figure 61. SAMEA Liganlong Granules Revenue Share by Type (2021-2032) Figure 62. SAMEA Liganlong Granules Sales Share by Type (2021-2032) Figure 63. SAMEA Liganlong Granules Revenue Share by Application (2021-2032) Figure 64. SAMEA Liganlong Granules Sales Share by Application (2021-2032) Figure 65. SAMEA Liganlong Granules Revenue Share by Country (2021-2032) Figure 66. SAMEA Liganlong Granules Sales Share by Country (2021-2032) Figure 67. Liganlong Granules Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Liganlong Granules Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 5g
  • 10g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Zhongjing Wanxi Pharmaceutical Co., Ltd.
  • Tibet Tibetan Medicine Group Co., Ltd.
  • Sichuan Luye Pharmaceutical Co., Ltd.
  • Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.
  • Liaoning Keji Pharmaceutical Co., Ltd.
  • Liaoning Dongyi Pharmaceutical Co., Ltd.
  • Jiangxi Chuanqi Pharmaceutical Co., Ltd.
  • Jilin Yatai Pharmaceutical Co., Ltd.
  • Jilin Yinoke Pharmaceutical Co., Ltd.
  • Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  • Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  • Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.
  • Hainan Zhongbao Pharmaceutical Co., Ltd.
  • Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  • Guizhou Dalong Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  • Guangxi Xiuzhen Pharmaceutical Co., Ltd.
  • Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
  • Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.
  • Dalian Meiluo Chinese Medicine Factory Co., Ltd.
  • Dalian Hanfang Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liganlong Granules Market by Type
  3. 1.2.1 Global Liganlong Granules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5g
  5. 1.2.3 10g
  6. 1.3 Liganlong Granules Market by Application
  7. 1.3.1 Global Liganlong Granules Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Liganlong Granules Market Dynamics
  1. 2.1 Liganlong Granules Industry Trends
  2. 2.2 Liganlong Granules Industry Drivers
  3. 2.3 Liganlong Granules Industry Opportunities and Challenges
  4. 2.4 Liganlong Granules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Liganlong Granules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Liganlong Granules Revenue by Region
  3. 3.2.1 Global Liganlong Granules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liganlong Granules Revenue by Region (2021-2026)
  5. 3.2.3 Global Liganlong Granules Revenue by Region (2027-2032)
  6. 3.2.4 Global Liganlong Granules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Liganlong Granules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Liganlong Granules Sales by Region
  9. 3.4.1 Global Liganlong Granules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Liganlong Granules Sales by Region (2021-2026)
  11. 3.4.3 Global Liganlong Granules Sales by Region (2027-2032)
  12. 3.4.4 Global Liganlong Granules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Liganlong Granules Revenue by Manufacturers
  2. 4.1.1 Global Liganlong Granules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Liganlong Granules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Liganlong Granules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liganlong Granules Sales by Manufacturers
  6. 4.2.1 Global Liganlong Granules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Liganlong Granules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Liganlong Granules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Liganlong Granules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Liganlong Granules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Liganlong Granules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Liganlong Granules Manufacturers, Product Type & Application
  13. 4.7 Global Liganlong Granules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Liganlong Granules Market CR5 and HHI
  16. 4.8.2 2025 Liganlong Granules Tier 1, Tier 2, and Tier 3
5 Liganlong Granules Market by Type
  1. 5.1 Global Liganlong Granules Revenue by Type
  2. 5.1.1 Global Liganlong Granules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Liganlong Granules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Liganlong Granules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Liganlong Granules Sales by Type
  6. 5.2.1 Global Liganlong Granules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liganlong Granules Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Liganlong Granules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Liganlong Granules Price by Type
6 Liganlong Granules Market by Application
  1. 6.1 Global Liganlong Granules Revenue by Application
  2. 6.1.1 Global Liganlong Granules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Liganlong Granules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Liganlong Granules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Liganlong Granules Sales by Application
  6. 6.2.1 Global Liganlong Granules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Liganlong Granules Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Liganlong Granules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Liganlong Granules Price by Application
7 Company Profiles
  1. 7.1 Zhongjing Wanxi Pharmaceutical Co., Ltd.
  2. 7.1.1 Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  6. 7.1.5 Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Tibet Tibetan Medicine Group Co., Ltd.
  8. 7.2.1 Tibet Tibetan Medicine Group Co., Ltd. Company Information
  9. 7.2.2 Tibet Tibetan Medicine Group Co., Ltd. Business Overview
  10. 7.2.3 Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Product Portfolio
  12. 7.2.5 Tibet Tibetan Medicine Group Co., Ltd. Recent Developments
  13. 7.3 Sichuan Luye Pharmaceutical Co., Ltd.
  14. 7.3.1 Sichuan Luye Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Sichuan Luye Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  18. 7.3.5 Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.
  20. 7.4.1 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  24. 7.4.5 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Liaoning Keji Pharmaceutical Co., Ltd.
  26. 7.5.1 Liaoning Keji Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Liaoning Keji Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  30. 7.5.5 Liaoning Keji Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Liaoning Dongyi Pharmaceutical Co., Ltd.
  32. 7.6.1 Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  36. 7.6.5 Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Jiangxi Chuanqi Pharmaceutical Co., Ltd.
  38. 7.7.1 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  42. 7.7.5 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Recent Developments
  43. 7.8 Jilin Yatai Pharmaceutical Co., Ltd.
  44. 7.8.1 Jilin Yatai Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Jilin Yatai Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  48. 7.8.5 Jilin Yatai Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Jilin Yinoke Pharmaceutical Co., Ltd.
  50. 7.9.1 Jilin Yinoke Pharmaceutical Co., Ltd. Company Information
  51. 7.9.2 Jilin Yinoke Pharmaceutical Co., Ltd. Business Overview
  52. 7.9.3 Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  54. 7.9.5 Jilin Yinoke Pharmaceutical Co., Ltd. Recent Developments
  55. 7.10 Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  56. 7.10.1 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information
  57. 7.10.2 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview
  58. 7.10.3 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  60. 7.10.5 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Developments
  61. 7.11 Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  62. 7.11.1 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information
  63. 7.11.2 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
  64. 7.11.3 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  66. 7.11.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Developments
  67. 7.12 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.
  68. 7.12.1 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Company Information
  69. 7.12.2 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Business Overview
  70. 7.12.3 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  72. 7.12.5 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Recent Developments
  73. 7.13 Hainan Zhongbao Pharmaceutical Co., Ltd.
  74. 7.13.1 Hainan Zhongbao Pharmaceutical Co., Ltd. Company Information
  75. 7.13.2 Hainan Zhongbao Pharmaceutical Co., Ltd. Business Overview
  76. 7.13.3 Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  78. 7.13.5 Hainan Zhongbao Pharmaceutical Co., Ltd. Recent Developments
  79. 7.14 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  80. 7.14.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
  81. 7.14.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
  82. 7.14.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  84. 7.14.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
  85. 7.15 Guizhou Dalong Pharmaceutical Co., Ltd.
  86. 7.15.1 Guizhou Dalong Pharmaceutical Co., Ltd. Company Information
  87. 7.15.2 Guizhou Dalong Pharmaceutical Co., Ltd. Business Overview
  88. 7.15.3 Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  90. 7.15.5 Guizhou Dalong Pharmaceutical Co., Ltd. Recent Developments
  91. 7.16 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  92. 7.16.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
  93. 7.16.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
  94. 7.16.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  96. 7.16.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
  97. 7.17 Guangxi Xiuzhen Pharmaceutical Co., Ltd.
  98. 7.17.1 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Company Information
  99. 7.17.2 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Business Overview
  100. 7.17.3 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  102. 7.17.5 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Recent Developments
  103. 7.18 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
  104. 7.18.1 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Company Information
  105. 7.18.2 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Business Overview
  106. 7.18.3 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  108. 7.18.5 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Recent Developments
  109. 7.19 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.
  110. 7.19.1 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Company Information
  111. 7.19.2 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Business Overview
  112. 7.19.3 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Product Portfolio
  114. 7.19.5 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Recent Developments
  115. 7.20 Dalian Meiluo Chinese Medicine Factory Co., Ltd.
  116. 7.20.1 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Company Information
  117. 7.20.2 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Business Overview
  118. 7.20.3 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Product Portfolio
  120. 7.20.5 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Recent Developments
  121. 7.21 Dalian Hanfang Pharmaceutical Co., Ltd.
  122. 7.21.1 Dalian Hanfang Pharmaceutical Co., Ltd. Company Information
  123. 7.21.2 Dalian Hanfang Pharmaceutical Co., Ltd. Business Overview
  124. 7.21.3 Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  126. 7.21.5 Dalian Hanfang Pharmaceutical Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Liganlong Granules Market Size by Type
  2. 8.1.1 North America Liganlong Granules Revenue by Type (2021-2032)
  3. 8.1.2 North America Liganlong Granules Sales by Type (2021-2032)
  4. 8.1.3 North America Liganlong Granules Price by Type (2021-2032)
  5. 8.2 North America Liganlong Granules Market Size by Application
  6. 8.2.1 North America Liganlong Granules Revenue by Application (2021-2032)
  7. 8.2.2 North America Liganlong Granules Sales by Application (2021-2032)
  8. 8.2.3 North America Liganlong Granules Price by Application (2021-2032)
  9. 8.3 North America Liganlong Granules Market Size by Country
  10. 8.3.1 North America Liganlong Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Liganlong Granules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Liganlong Granules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Liganlong Granules Market Size by Type
  2. 9.1.1 Europe Liganlong Granules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Liganlong Granules Sales by Type (2021-2032)
  4. 9.1.3 Europe Liganlong Granules Price by Type (2021-2032)
  5. 9.2 Europe Liganlong Granules Market Size by Application
  6. 9.2.1 Europe Liganlong Granules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Liganlong Granules Sales by Application (2021-2032)
  8. 9.2.3 Europe Liganlong Granules Price by Application (2021-2032)
  9. 9.3 Europe Liganlong Granules Market Size by Country
  10. 9.3.1 Europe Liganlong Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Liganlong Granules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Liganlong Granules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Liganlong Granules Market Size by Type
  2. 10.1.1 China Liganlong Granules Revenue by Type (2021-2032)
  3. 10.1.2 China Liganlong Granules Sales by Type (2021-2032)
  4. 10.1.3 China Liganlong Granules Price by Type (2021-2032)
  5. 10.2 China Liganlong Granules Market Size by Application
  6. 10.2.1 China Liganlong Granules Revenue by Application (2021-2032)
  7. 10.2.2 China Liganlong Granules Sales by Application (2021-2032)
  8. 10.2.3 China Liganlong Granules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liganlong Granules Market Size by Type
  2. 11.1.1 Asia Liganlong Granules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Liganlong Granules Sales by Type (2021-2032)
  4. 11.1.3 Asia Liganlong Granules Price by Type (2021-2032)
  5. 11.2 Asia Liganlong Granules Market Size by Application
  6. 11.2.1 Asia Liganlong Granules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Liganlong Granules Sales by Application (2021-2032)
  8. 11.2.3 Asia Liganlong Granules Price by Application (2021-2032)
  9. 11.3 Asia Liganlong Granules Market Size by Country
  10. 11.3.1 Asia Liganlong Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Liganlong Granules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Liganlong Granules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liganlong Granules Market Size by Type
  2. 12.1.1 SAMEA Liganlong Granules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Liganlong Granules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Liganlong Granules Price by Type (2021-2032)
  5. 12.2 SAMEA Liganlong Granules Market Size by Application
  6. 12.2.1 SAMEA Liganlong Granules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Liganlong Granules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Liganlong Granules Price by Application (2021-2032)
  9. 12.3 SAMEA Liganlong Granules Market Size by Country
  10. 12.3.1 SAMEA Liganlong Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Liganlong Granules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Liganlong Granules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Liganlong Granules Value Chain Analysis
  2. 13.1.1 Liganlong Granules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Liganlong Granules Production Mode & Process
  6. 13.2 Liganlong Granules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Liganlong Granules Distributors
  9. 13.2.3 Liganlong Granules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst